03/16/2026
--Cannabis Compounds Show Promise for Fatty Liver Disease--
New research from the Hebrew University of Jerusalem suggests that two cannabis compounds, CBD and CBG, may help reverse fatty liver disease and improve metabolic health. These non-intoxicating cannabinoids appear to help the liver burn fat and restore key cellular systems that keep liver cells healthy. With fatty liver disease now affecting about one-third of adults worldwide, researchers are searching for better treatment options. Lifestyle changes such as diet and exercise remain important, but they can be difficult to maintain long-term, and there are still very few medications available. That is why scientists are increasingly exploring plant-based compounds that may support the body’s natural metabolic systems.
In this new study, CBD and CBG helped liver cells in two important ways. First, the compounds increased levels of phosphocreatine, a molecule that acts like an emergency energy supply for cells under stress. Second, they restored the activity of enzymes that act like cellular “recycling centers,” helping the liver break down harmful fats and metabolic waste. As a result, researchers observed significant reductions in damaging lipids such as triglycerides and ceramides, along with improved blood sugar control.
Interestingly, both cannabinoids improved metabolic health, but CBG showed even stronger effects in several areas. The compound reduced body fat mass, improved insulin sensitivity, and lowered total cholesterol and LDL cholesterol. While more research is needed before these findings translate into treatments for people, the results point to an exciting possibility: cannabis-derived compounds may help support liver health and metabolic balance. Studies like this continue to highlight cannabis's growing potential as a hopeful tool in modern medicine.
